Mechanism of Chemotherapy Resistance of Hepatocellular Carcinoma and Intervention with Chinese Medicine： A Review
10.13422/j.cnki.syfjx.20220923
- VernacularTitle:肝癌化疗耐药机制及中药干预研究进展
- Author:
Zeyu HU
1
;
Qingrui YANG
1
;
Cheng ZHOU
2
;
Lin YANG
3
;
Haijuan XIAO
1
;
Yu FANG
1
Author Information
1. Shaanxi University of Chinese Medicine， Xianyang 712046， China
2. The First Clinical Medical College of Henan University of Chinese Medicine， Zhengzhou 450046， China
3. Xianyang Central Hospital， Xianyang 712000， China
- Publication Type:Journal Article
- Keywords:
Chinese medicine;
primary hepatocellular carcinoma;
chemotherapy resistance;
reversal mechanism;
multidrug resistance
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2022;28(14):254-261
- CountryChina
- Language:Chinese
-
Abstract:
Multidrug resistance （MDR） has been a main culprit behind the failure of chemotherapy in patients with malignant tumors and a major obstacle to improving the life quality and prolonging the survival of patients. Hepatocellular carcinoma cells， the innate drug-resistant cells， are generally insensitive to radiotherapy and chemotherapy. Moreover， as the early symptoms of hepatocellular carcinoma are atypical， most patients are diagnosed at the advanced stage， with short survival period and high recurrence rate. Thus， the sensitivity to chemotherapy drugs is decreased. This explains how MDR becomes one of the important reasons for the failure of primary hepatocellular carcinoma （PHC） treatment. Therefore， it is an urgent task to search for safe and effective chemosensitizers with little adverse effect in the research on the drug resistance of hepatocellular carcinoma. As Chinese medicine has been widely applied in the treatment of tumors， the mechanisms of compound Chinese medicine prescriptions， Chinese medicine injections， and single Chinese medicinal in reversing chemotherapy resistance in liver cancer have attracted the interest of scholars. According to previous reports， the mechanisms can be summarized as increasing intracellular drug concentration， influencing changes in enzyme activity， inducing apoptosis， reversing abnormalities in cellular signaling pathways， and regulating the tumor microenvironment. Traditional Chinese medicine reduces the chemotherapy resistance of hepatocellular carcinoma cells through multiple targets and multiple pathways， thereby improving the chemotherapy sensitivity of the cancer cells and enhancing the toxicity of chemotherapeutic drugs to hepatocellular carcinoma cells. Therefore， exploring the mechanism of MDR of hepatocellular carcinoma from the perspective of traditional Chinese medicine is important for reversing the MDR and is of great reference value for clinical treatment of hepatocellular carcinoma. However， there are few experimental types and adverse effects available. Thus， the multi-mechanism and multi-target experiments and clinical research should be carried out in the future.
